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280 S.A. Elkaradawy et al.postoperatively. Second outcome measured dynamic stress (perioperative heart rate, blood pressure
and postoperative pain).
Results: Endothelin-1 was above cutoff level preoperatively and rose up dramatically postopera-
tively in both studied groups. G/EP attenuated ET-1 elevation than G/O. Troponin T and CK-MB
did not rise postoperatively in both studied groups. Postoperative CK-MB/ CK ratio was higher than
10% in 12 and eight patients in group G/O and G/EP, respectively. Twelve cardiac ischaemic events
were noticed in four patients in group G/O and four events in two patients in group G/EP without
signiﬁcant difference in total duration of ischaemia between groups. G/EP lowered HR more signif-
icantly intraoperatively and gave better pain control for 4 h postoperatively. In conclusion, D.M was
associated with high ET-1 level. Upper abdominal surgery increased ET-1 release. G/EP attenuated
ET-1 release more than G/O and produced more stable haemodynamic parameters and less
postoperative pain. No superior cardioprotective effect was noticed in G/EP over G/O.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
The incidence of patients with diabetes mellitus (D.M) under-
going surgical procedures increases each year. This incidence is
going to rise as prevalence of diabetes is predicted to be 300
million by the end of 2025. Diabetes mellitus is a major risk
factor for perioperative cardiac complications and death.
Myocardial ischaemia in particular is the most frequent com-
plication in patients with diabetes and accounts for approxi-
mately 1.4% in patients undergoing noncardiac surgery. It is
often lethal, increases cost of hospital stay and compromises
a patient’s quality of life after surgery [1,2].
Attempts to improve perioperative outcome of diabetic pa-
tients with risk for developing coronary artery disease (CAD)
have focused on two main approaches. The ﬁrst is deep under-
standing to the pathogenesis of D.M and its impact on cardio-
vascular disease. This can help in early diagnosis and better
management of cardiovascular sequence. The second is to
attenuate deleterious effect of surgical stress in those patients
using a preventive anaesthetics [2].
The persistent hyperglycemia is a risk factor for developing
endothelial dysfunction that enhances atherosclerotic cardiovas-
cular complications in patients with diabetes [3]. It stimulates
cytokines production that decreases the new synthesis of collagen
by vascular smooth muscle cells. So it alters vascular smooth
muscle function and favouring atherosclerosis formation. Fur-
thermore, diabetes enhances the release of some protolytic en-
zymes that lead to breakdown of collagen. When collagen
breakdown increases and synthesis decreases, atheromatous pla-
quesmay rupturemore easily, triggering thrombus formation [4].
Diabetes mellitus enhances endothelin-1 (EL-1) release. It is
a potent vasoconstrictor deriving from endothelium cells and
stimulated by several stimuli such as renal failure, ischaemic
heart disease, systemic or pulmonary hypertension [5]. It is
suggested that increased endothelin in diabetes is responsible
for development of its cardiovascular sequel. Recent investiga-
tions [6,7] reported higher concentrations of ET-1 in serum of
patients with ischaemic heart disease, particularly its unstable
character. High values were observed in patients with myocar-
dial infarction and heart failure. Although it has high sensitiv-
ity towards cardiovascular disease (CVD), its low speciﬁcity
could not make it a standard predictor of postoperative
cardiovascular outcome in diabetics.
Lastly, diabetes is frequently associated with silent ischae-
mia. Autonomic neuropathy is suggested to be the main factor
for relatively high incidence of painless ischaemia in diabetics[8]. So patients do not report chest pain and myocardial infarc-
tion may be suddenly discovered at preoperative time. Accord-
ingly, pathogenesis of diabetes makes careful preoperative
assessment of cardiovascular to be very essential.
Surgery is characterised by a hypercoagulable response due
to increased platelet number and function, diminished ﬁbrino-
lysis, decreased natural anticoagulants and increased procoag-
ulants. Hypercoagulable response in addition to sympathetic
activation caused by intra and postoperative stress is an impor-
tant factor mediating the increased incidence of perioperative
coronary insufﬁciency [9,10]. Therefore, types of anaesthesia
delivered to patients with diabetes should target to reduce neu-
ro-hormonal surgical stress and improve overall outcome after
surgery. Considerable debate still remains over the advantages
and disadvantages of combined regional–general anaesthesia
compared with general anaesthesia in prevention of cardiovas-
cular dysfunction in the patient with diabetes undergoing non-
cardiac surgery [11].2. Aim of the work
The aim of the current study was to investigate the effect of
general anaesthesia with intraoperative and postoperative i.v.
opioid analgesia or thoracic epidural analgesia on some clini-
cal and biochemical predictors of postoperative transient myo-
cardial ischaemia in patients with D.M type 2 undergoing
upper abdominal surgery.3. Participants and methods
After obtaining Ethical Committee approval of Medical
Research Institute and taking patients’ consents, the current
randomised controlled parallel-group study was conducted
on 50 patients with diabetes mellitus type 2 scheduled for open
cholecystectomy.
3.1. Inclusion criteria
All patients were American Society of Anesthesiologists phys-
ical status II (ASA 11), scheduled for open cholecystectomy at
Medical Research Institute hospital, Alexandria University,
Egypt. They all have D.M type 2, glycosylated haemoglobin
was <8.5%, negative stress exercise test to exclude preopera-
tive ischaemic coronary disease therefore helping in evaluating
the preventive role of the two analgesic techniques on postop-
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factors for developing coronary artery disease: in addition to
D.M and abdominal surgery, Age >60 years, sedentary
lifestyle, total cholesterol P240 mg/dl, LDLP 160 mg/dl, or
HDL <35 mg/dl, current smoking, family history of
premature CAD[12].
3.2. Exclusion criteria
Any patient with history of coronary artery disease, heart
failure, hypertension, respiratory, renal or hepatic insufﬁ-
ciency, having any contraindications for epidural anaesthesia
was excluded from the study.
3.3. Randomisation and blinding of the study
A block-wise balanced randomisation procedure was used.
The allocation to general anaesthesia with either opioid anal-
gesia or thoracic epidural analgesia was done on cards that
were sealed into opaque and consecutively numbered enve-
lopes. These envelopes were opened after taking decision for
operation. Data collection and analysis were conducted by a
neutral researcher who was blinded with anaesthetic and anal-
gesic techniques.
3.4. Anaesthesia and patients’ grouping
Patients were divided according to types of perioperative
analgesia into general anaesthesia with continuous opioid anal-
gesia (Group G/O) or thoracic epidural analgesia (Group G/EP).
3.5. Epidural block
After preparation of skin and while patient was in sitting posi-
tion, 19 G epidural catheter was inserted through Toughy nee-
dle and advanced 3 cm in epidural space between 7th and 8th
thoracic vertebra using loss of resistance to air technique. Epi-
dural blockade was established with initial bolus of 15 ml of
ropivacaine 0.2% with fentanyl 2 lg/ml then an infusion pump
started to provide a continuous mixture of 5–8 ml/h of
ropivacaine 0.1% and fentanyl 1 lg/ml epidural for 24 h
postoperatively.
3.6. General anaesthesia
All patients were premedicated with midazolam 0.03 mg/kg and
fentanyl 0.5 lg/kg intravenously just before transfer to opera-
tive theatre. Induction of general anaesthesia in both studied
groups was carried out using: fentanyl 2 lg/kg, propofol 1–
2 mg/kg, and atracurium 0.5 mg/kg for tracheal intubation.
Anaesthesia was maintained with isoﬂurane1-2%, air–oxygen
mixture and atracurium 0.3 mg/kg. Atracurium was given to
maintain one twitch of train of four of nerve stimulation.
3.7. Analgesic requirement
Intraoperative analgesic requirement in group G/O was
achieved with continuous i.v. fentanyl 100 lg/h. Postoperative
analgesia was maintained by i.v. morphine patient control
analgesia (PCA) (Master PCA, Fresenius-KABI) at concentra-
tion of 1 mg/ml using 1 ml/h basal rate and 1 ml PCA withlock out time 6 min and 10 ml maximum dose/hour for the ﬁrst
6 h then 1 ml PCA bolus doses was used without continuous
basal rate infusion for the entire 24 h postoperative.
3.8. Measurements
Plasma lipid proﬁle including triglyceride, total cholesterol (TC)
concentration, high density lipoprotein cholesterol (HDL-C)
and low density lipoprotein cholesterol (LDL-C) were analysed
by an autoanalyser (Hitachi 7170, Tokyo, Japan) [13]. It was
measured preoperatively to recognise diabetic patient with high
risk to develop coronary artery disease.
Cardiac ischaemia was evaluated biochemically and clini-
cally. Biochemical evaluation measured plasma endothelin-1
and serum cardiac biomarkers; creatine kinase (CK), MB
fraction (CK-MB) and cardiac troponin T (cTnT). They were
assessed preoperatively, 8 h and 24 h postoperatively. Estima-
tion of EDTA plasma ET-1 level was done using noncompet-
itive sandwich immunosorbance assay (R&D systems kit
(catalog#BBE5) Minneapolis, MN, USA). After the extraction
procedure for plasma samples, the standards, controls and
extracted plasma were added into the wells that pre-coated
with ET-1 antibodies. Then any ET-1 present was sandwiched
by the horseradish peroxidase enzyme-linked to speciﬁc ET-1
antibody conjugate. After an incubation and washing steps,
a substrate solution (tetamethyl benzidine) was added to the
wells and the intensity of the colour was stopped by acid solu-
tion after the second incubation. The intensity of the colour
was measured using microplate reader set at 450 nm and
620 nm. Subtraction of reading at 620 from that 450 nm to
correct for optical imperfections in the plate. The concentra-
tions of ET-1 in the samples were obtained from standard
curve drawn on semi logarithmic paper, where the concentra-
tion of standard on the X-axis and mean absorbance of each
standard on the Y-axis. The cutoff EDTA plasma ET-1 value
was 0.6 ± 0.2 pg/ml. CK and CK-MB fraction were measured
by autoanalyser technique. The upper limit of normal for CK
total was 170 U/l [13]. The CK-MB increase was considered
positive (CKMB+) when total CK elevation was twice base-
line, with the ratio of CK-MB to total CK >10% of total
CK, as determined from serial samples at 8 h and 24 h postop-
eratively [14]. Troponin T enzyme immunoassay (Boehringer
Mannheim, Germany, and ELISA (ES-300) analyser) were
used for cTnT assay. Normal cTnT reading ranged 0.0–
0.1 ng/ml, values of >0.1 ng/ml were therefore considered to
be positive [15].
Clinical evaluation was done by ST segment analysis using
24 h continuous postoperative digital ambulatory 3 leads ECG
recorder (VX3-E 2710, USA) with compact ﬂash ELITE 512
PROE. ST Segment was analysed by expert cardiologist who
was blinded to research design. Transient myocardial ischae-
mia (TMI) was deﬁned as an elevation or a depression in the
ST level from baseline in one or more leads lasting one or more
minutes. Total numbers of ischaemic events per 24 h and their
duration were calculated [16].
Stress of surgery was assessed clinically. Clinical parameters
included perioperative heart rate (HR) and mean arterial
blood pressure (MABP) that was measured 10 min interval
intraoperatively and at postanaesthetic care unit (PACU)
admission then every 4 h for 24 h postoperatively. In addition
visual analogue scale (VAS) (0–10 cm) for assessment of post-
operative pain was recorded every 4 h postoperatively. Total
282 S.A. Elkaradawy et al.morphine and ropivacaine fentanyl mixture were calculated for
24 h postoperatively.
Postoperative complications including excessive sedation,
nausea, vomiting pruritus and/or motor paresis were recorded.
3.9. Statistical analysis
Data were analysed using SPSS software version 18.0. The
sample size was calculated using NCSS 2003. Twenty-ﬁve
patients in each studied group achieved 91% power at alpha
0.05 and detected the difference between groups based on pre-
vious study [17] on ET-1 (mean = 2.0 ± SD= 0.2) as
biomarker of biomechanical stress after surgery and cardiac
troponin T [18] as a diagnostic biomarker of ischaemia under
the inﬂuence of epidural analgesia using two sided Mann–
Whitney. Quantitative data were expressed as mean ± SD
and analysed using Student t test for comparing two studied
groups and Paired t test for comparing values in same group.
When multiple comparisons were made in same group, the
Bonferroni correction was applied. Qualitative data (sex, num-
ber of ischaemic events and association of ischaemic events,
CK-MB and ET-1) were representing in frequency, percent
and analysed using Chi square test and Fisher exact test. P
value was assumed to be signiﬁcant at 0.05 or less.
4. Results
Demographic data were matching in both studied groups.
Preoperative risk factors for developing perioperativeTable 1 Demographic data and patients’ characteristic in the studi
Variable Group G/O
Age (years) 44.12±6.0
Sex (female)/(male) 20/5
Weight (kg) 87.52 ± 7.
Risk factors for cardiac disease in diabetics
CholesterolP 250 mg/dl 7 patients
LDLP 160 mg/dl 12 patients
HDL 6 35 mg/dl 12 patients
Triglycerides > 200 mg/dl 9 patients
Smoking 5 patients
Family history of CAD 5 patients
Duration (years) of D.M 7.72 ± 3.1
Values are expressed as (mean ± SD). G/O = general anaesthesia with
*P 6 0.05 is considered signiﬁcant.
Table 2 Cardiac biomarkers (endothelin-1, troponin T and creatin
Time/variables Group G/O (n= 25)
Preoperative 4 h postoperative 24 h posto
Endothelin-1 (pg/ml) 0.95 ± 0.28 2.59*,#± 0.78 2.66 ± 0.7
Troponin T (ng/ml) 0.028 ± 0.004 0.029 ± 0.011 0.026 ± 0
CK-MB (U/l) 12.60 ± 3.66 15.24 ± 5.9 15.6 ± 5.6
CK total (U/l) 82.52 ± 18.43 184.20 ± 35.70* 176.72 ±
G/O= general anaesthesia with i.v. opioids; G/EP = general anaesthesi
* P 6 0.025 is considered signiﬁcant for Paired t test (after Bonferroni co
# P 6 0.05 is considered signiﬁcant for Student t test.myocardial ischaemia and duration of diabetes did not show
signiﬁcant difference between the studied groups (Table 1).
Plasma endothelin-1 was above cutoff level at preoperative
time and rose up dramatically at postoperative time in both
studied groups. But its rise was less in group G/EP than group
G/O. Troponin T and CK-MB did not show signiﬁcant rise at
postoperative time compared to preoperative values in both
studied groups. In spite of that, CK-MB/CK total was noticed
to be higher than 10% in twelve patients in group G/O and
eight patients in group G/EP postoperatively (Table 2).
Analysis of postoperative cardiac ischaemic events showed
12 cardiac ischaemic events (mostly ST segment depression) in
four patients in group G/O with mean duration of 7.25 min
and four events in two patients in group G/EP with mean
duration of 7.50 min. Number and duration of these ischaemic
insults did not signiﬁcantly differ between the studied groups
(Table 3). All patients with ischaemic events did not report
clinical cardiac symptoms except one in group G/O reported
brief chest tightness. Three of four patients (75%) with cardiac
events have positive CK-MB/CK ratio (>10%) in group G/O
and two of two (100%) in group G/EP. No signiﬁcant associ-
ation between ischaemic events and CK-MB ratio in both
studied groups. All patients with ischaemic insult in both
groups (100%) have elevated ET-1 but none of them got high
troponin level (Table 4).
Intraoperative heart rate and blood pressure showed steady
decline compared with preoperative reading in both groups.
Addition of epidural analgesia to general anaesthesia lowered
HR signiﬁcantly intraoperatively but it did not decrease blooded groups.
(n= 25) Group G/EP (n= 25)
6 44.08±5.94
18/7
37 89.40 ± 9.56
9 patients
10 patients
9 patients
7 patients
6 patients
9 patients
4 8.80 ± 4.28
i.v. opioids; G/EP = general anaesthesia with epidural analgesia.
e kinase) in both studied groups (mean ± SD).
Group G/EP (n= 25)
perative Preoperative 4 h postoperative 24 h postoperative
4*,# 1.00 ± 0.20 2.02 ± 0.70*,# 2.14 ± 0.75*,#
.019 0.027 ± 0.02 0.027 ± 0.019 0.0219 ± 0.018
7 13.90 ± 3.05 14.96 ± 3.41 15.36 ± 4.16
34.24* 86.44 ± 13.80 180.28 ± 37.6* 175.78 ± 33.36*
a with epidural analgesia.
rrection).
Table 4 Association of cardiac ischaemic events, CK-MB/CK, and endothelin-1.
CK-MB/CK
positive (P)
Postoperative Endothelin-1
above cutoﬀ value (P)
Ischaemic events positive G/O 75% (0.322) 100% (1.000)
Ischaemic events positive G/EP 100% (0.093) 100% (0.093)
G/O = general anaesthesia with i.v. opioids; G/EP = general anaesthesia with epidural analgesia. *P 6 0.05 is considered signiﬁcant.
Table 3 Cardiac ischaemic events in both studied groups (mean ± SD).
Number of
patients
Total number of
ischaemic events
Mean duration/min of
ischaemic events (mean ± SD)
ST segment
change
Group G/O (n= 25) 4(16%) 12 7.25±3.77 Depression
Group G/EP (n= 25) 2(8%) 4 7.50±4.94 Depression
P 0.666 0.353 0.601
G/O= general anaesthesia with i.v. opioids; G/EP = general anaesthesia with epidural analgesia. *P 6 0.05 is considered signiﬁcant.
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tively or postoperatively (Figs. 1–4).
Visual analogue scale was signiﬁcantly less in group G/EP
immediately and 4 h postoperative compared with group
G/O. After that time there was no signiﬁcant difference in
VAS between the two groups Fig. 5.Figure 1 Intraoperative mean heart rate (beats/min) G/O = genera
epidural analgesia.
Figure 2 Intraoperative mean arterial blood pressure (mm/Hg) in b
G/EP = general anaesthesia with epidural analgesia.Mean morphine consumption in 24 h postoperatively was
15.2 mg ± 4.052 in group G/O and ropivacain/fentanyl mix-
ture was 128 mg ropivacaine/128 lg fentanyl ± 17.32 in group
G/EP.
With regard to postoperative complications seven patients
in group G/O and two patients in group G/EP complainedl anaesthesia with i.v. opioids. G/EP = general anaesthesia with
oth studied groups G/O = general anaesthesia with i.v. opioids,
Figure 3 Postoperative mean heart rate (beats/min) in both studied groups G/O = general anaesthesia with i.v. opioids, G/
EP = general anaesthesia with epidural analgesia.
Figure 4 Postoperative mean blood pressure (mm/Hg) in both studied groups G/O = general anaesthesia with i.v. opioids,
G/EP = general anaesthesia with epidural analgesia.
Figure 5 Visual analogue scale (0–10 cm) in both studied groups G/O = general anaesthesia with i.v. opioids, G/EP = general
anaesthesia with epidural analgesia.
284 S.A. Elkaradawy et al.of nausea, vomiting. Five patients have drowsiness in group G/
O and one in group G/EP. There was no signiﬁcant difference
in postoperative complications between the studied groups.
5. Discussion
All anaesthetists are aware that diabetic patients undergoing
abdominal surgery may be at a risk for developing periopera-
tive myocardial ischaemia. Sustained stress and increased met-
abolic demand during perioperative period in addition to
diabetes associated endothelial dysfunction and autonomic
neuropathy increase the chance of postoperative cardiovascular
complications. Therefore, screening of preoperative cardiovas-
cular risk, administration of prophylactic medications and
balanced anaesthesia may achieve better cardiovascular
outcome [19].
All diabetic patients included in the current study have
cardiovascular risks at preoperative time. Seven patients hadcholesterol level above 240 mg/dl in group G/O and nine pa-
tients in group G/EP. Twelve patients in group G/O and 10
patients in group G/EP had LDL higher than 160 mg/dl.
HDL less than 35 mg/dl was observed in 12 and nine patients
in group G/O and G/EP, respectively. Triglycerides level more
than 200 mg/dl was noticed in nine patients in group G/O and
seven patients in group G/EP. Smoking and family history of
ischaemic heart disease were reported by 10 patients in group
G/O and 15 patients in group G/EP.
Dyslipidaemia is a common pathogenesis associated with
D.M. It may precede signs and symptoms of D.M by several
years and may be the primary factor in developing both
D.M and atherosclerotic cardiovascular disease (CVD) [20].
The positive correlation between hypercholesterolaemia (core
stone of atherosclerotic plaque) and CVD had been evident
in previous studies [21,22]. Hypertriglyceridaemia as a risk
promoting CVD has been debated. Earlier studies [23,24]
failed to ﬁnd strong association of triglyceride and coronary
Silent myocardial ischaemia in diabetic patients after general anaesthesia with 24 h 285artery disease after adjustment of either total cholesterol and
LDL (univariate analysis). However, latter meta-analysis [25]
showed that, hypertriglyceridaemia in combination with low
HDL-C was considered unique risk for CVD (multivariate
analysis). Miller et al. [26] supported strong link between high
triglyceride and CVD in people with lower levels of HDL-C
and LDL-C with type 2 diabetes. Smoking is another cardiac
risk factor producing severe vascular spasm [27]. All previous
cardiovascular risks were recommended to be screened by
American Diabetes Association and Socie´te´ Franc¸aise de Car-
diologie/Association de Langue Franc¸aise pour l’Etude du
DIAbe`te et des Maladies me´taboliques (SFC/ALFEDIAM)
for early diagnosis and better management [28].
Endothelin-1 is a 21-amino-acid peptide released from
endothelial cells and exerts diverse actions in the cardiovas-
cular system. It is a powerful vasoconstrictor and has direct
positive inotropic and chronotropic effects in the heart
[29].
In the current study, the mean basal value of endothelin-l
was above cutoff level in the studied groups preoperatively
under the inﬂuence of diabetes. Surgical stress stimulates
ET-1 release and doubled its value postoperatively in both
studied groups. G/EP attenuated ET-1production more than
G/O. The attenuation of ET-1 production in G/EP may
explain in a part the decreased HR in this group. In addition,
it could exert more obvious protective role and give better
cardiovascular outcome if it was evaluated in larger sample
size.
The present result was consistent with the ﬁnding ob-
tained by Schneider et al. [30] who denoted that, diabetic
patients often have endothelial dysfunction and elevated
ET-1 level which was partly responsible for developing ath-
erosclerotic vascular insufﬁciency. Tsai et al. [17] reported
that, ET-1 associated D.M may lead to coronary vascular
tone abnormality and inappropriate coronary blood ﬂow
in response to increasing myocardial demand during and
after surgery. Shirakami et al. [31] investigated the effect
of major and minor surgery on perioperative ET-1 activity
and reported a signiﬁcantly increased plasma ET-1 level un-
der major surgical stress. However no signiﬁcant change was
observed in minor surgery. ET-1 activity was evaluated un-
der the effect of inhaled anaesthetics in a previous study
[32] which demonstrated that isoﬂuranee inhibited ET-1 vas-
cular contraction at 1 minimal alveolar concentration. It
also denoted that vasodilatation and hypotension induced
by inhaled anaesthetic may be attributed to interaction with
ET-1 at vascular endothelium cells. Taking this ﬁnding in
concern, attenuation of ET-1 under the inﬂuence of com-
bined general epidural anaesthesia could provide more pro-
tection on cardiovascular system by lowering HR and
reducing after load.
Although troponin T and CK-MB did not signiﬁcantly
change postoperatively in the present study, CK total was sig-
niﬁcantly increased and CK-MB/CK total was noticed to be
higher than 10% in 12 patients in group G/O and eight pa-
tients in group G/EP postoperatively. Postoperative troponin
and CK-MB readings showed that no irreversible cardiac
ischaemic insult occurred at postoperative time. Cardiac tro-
ponin and CK-MB are good biomarkers for diagnosing a myo-
cardial infarction. Troponin is more sensitive and more speciﬁc
than CK-MB. However, their release in response to reversible
injury has been debated for years [33]. In animal experiments,increased CK in blood was associated with evidence of irre-
versible cardiac injury [34].
Carlson et al. [35] and Babuin et al. [36] conﬁrmed that tro-
ponin elevations were not detected in humans after reversible
ischaemia.
Increased CK and ratio of CK-MB/CK total in the current
study may be as a result of surgical trauma. CK-MB is a good
marker strongly suggestive of acute coronary infarction in
acute medical condition. But it is difﬁcult to be as so good after
surgical procedure. Surgical trauma stimulated CK-MB release
from skeletal muscle and gave a false-positive CK-MB value
for MI. The speciﬁcity of CK-MB could be enhanced by the
calculation of the CK-MB/CK total ratio. However, the use
of this ratio markedly reduced sensitivity in patients with con-
current skeletal muscle injury [37,38].
In the present study, continuous cardiac ischaemic moni-
toring revealed 12 transient cardiac ischaemic events (mostly
ST segment depression) in four patients in group G/O and
four events in two patients in group G/EP. There was no sig-
niﬁcant difference in number or duration of ischaemic events
between the studied groups. This ﬁnding reported that G/EP
was not superior than G/O in prevention of cardiac ischae-
mia in the present research. Although, epidural analgesia
provided some beneﬁts over opioid analgesia in controlling
postoperative pain during the ﬁrst 4 h postoperatively, post-
operative pain was tolerable (VAS < 4 cm) in both studied
groups.
Proposed mechanisms for postoperative myocardial infarc-
tion are either neurohormonal–metabolic stress, endothelium
dysfunction and/or the release of inﬂammatory mediators.
The protective effect of general and regional anaesthesia on
decreasing stress response that could be reﬂected positively
on cardiovascular outcome was investigated in several previous
studies [39–42]. All concluded that high dose opioid based gen-
eral anaesthesia and high thoracic epidural general anaesthesia
can attenuate endocrine-metabolic effect in upper abdominal
surgery and could reduce perioperative myocardial ischaemia.
The role of volatile anaesthetics in reducing myocardial infarc-
tion size by preconditioning effect on coronary artery was re-
ported in one study [43]. In spite of these encouraging results,
a lot of debate still exists as use of high dose opioid needed post-
operative mechanical ventilation which increased the health
care cost. High epidural analgesia even very high up to C 6
failed in obtunding neurohormonal axis completely in upper
abdominal operation. Furthermore, none of previous anaes-
thetic techniques can suppress most of inﬂammatory mediators
or vasoconstrictor endothelial driving factors in response to
surgery [10].
In conclusion, type 2 D.M was associated with high ET-1
level at preoperative time. Surgical stress related to upper
abdominal operation increased ET-1 release postoperatively.
Patients with uncomplicated D.M type 2 underwent upper
abdominal surgery have a risk for developing TMI. G/EP
attenuated ET-1 release more than G/O and produced more
stable haemodynamic parameters and less postoperative pain.
No superior cardiovascular protective effect for G/EP over
G/O. Further investigations are recommended to evaluate
the effect of continuous perioperative epidural analgesia in
prevention of new cardiac ischaemia or re-ischaemia in pa-
tients with or without complications in D.M type 2, done
on large sample size and for more prolonged period (more
than 24 h).
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